Gene expression derived from alternative promoters improves prognostic stratification in multiple myeloma

Clinical and genetic risk factors are currently used in multiple myeloma (MM) to stratify patients and to design specific therapies. However, these systems do not capture the heterogeneity of the disease supporting the development of new prognostic factors. In this study, we identified active promot...

Descripción completa

Detalles Bibliográficos
Autores principales: Valcárcel, Luis V., Amundarain, Ane, Kulis, Marta, Charalampopoulou, Stella, Melnick, Ari, San Miguel, Jesús, Martín-Subero, José I., Planes, Francisco J., Agirre, Xabier, Prosper, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478642/
https://www.ncbi.nlm.nih.gov/pubmed/33972667
http://dx.doi.org/10.1038/s41375-021-01263-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478642/
https://www.ncbi.nlm.nih.gov/pubmed/33972667
http://dx.doi.org/10.1038/s41375-021-01263-9

Ejemplares similares